Recently, Saresella and colleagues found that inflammasome components (NLRP1, NLRP3, PYCARD, CASP1, CASP5, and CASP8) and downstream effectors (IL1B, IL18) were upregulated in peripheral blood mononuclear cells from patients with moderate and severe AD [70]. This evidence concerns the gene NLRP3 and Alzheimer disease.